Background Despite aggressive local therapy, patients with locally advanced bladder
cancer are at significant risk for metastases. We evaluated the ability of neoadjuvant …

Although prostate cancer (CaP) is the most frequently diagnosed malignant tumor and the
second leading cause of cancer deaths in American men, the mechanisms explaining the …

An androgen receptor (AR) gene mutation identified in the androgen-dependent human
prostate cancer xenograft, CWR22, changed codon 874 in the ligand-binding domain (exon H) …

Purpose : We investigated patient satisfaction with the artificial urinary sphincter and
established criteria for a successful outcome by inquiring about patient perceived satisfaction, …

Discussion Renal cell carcinoma is the most common primary renal parenchymal malignancy
in the United States. It is most common after the fifth decade of life and has a male–female …

Purpose Prostate cancer (PCa) is characterized by deregulated expression of several tumor
suppressor or oncogenic miRNAs. The objective of this study was the identification and …

BACKGROUND Prostate cancer mortality in the United States has declined by nearly 40%
over the last 25 years. However, to the authors' knowledge, the contribution of prostate‐…

BACKGROUND Increasing evidence demonstrates that aberrantly regulated microRNAs (miRNAs)
contribute to the initiation and progression of human cancer. We previously have …

BACKGROUND Docetaxel is the first line treatment for castration resistant prostate cancer (CRPC).
However, docetaxel resistance rapidly develops. Identifying the critical mechanisms …

Castration-resistant prostate cancer continues to rely on androgen receptor (AR) expression.
AR plays a central role in the development of prostate cancer and progression to castration …